Please login to the form below

Not currently logged in
Email:
Password:

BIO

This page shows the latest BIO news and features for those working in and with pharma, biotech and healthcare.

Sinovac begins late-stage COVID-19 vaccine trial

Sinovac begins late-stage COVID-19 vaccine trial

Chinese biotech company Sinovac has launched a phase 3 trial of its COVID-19 vaccine candidate CoronaVac, which is being developed in partnership with Indonesian state-owned enterprise Bio Farma. ... study. Bio Farma will increase its production capacity

Latest news

More from news
Approximately 28 fully matching, plus 205 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • EPG Health EPG Health

    Strategic planning - to ensure sustained engagement and ongoing success. Alexion, Almirall, Alnylam, AstraZeneca, Bial, Biogen, Bluebird Bio, Boehringer Ingelheim, BMS, CSL Behring, Ferring, Four Health, HRA Pharma, Janssen, Leo Pharma, Mylan,

  • HARNESSING TECHNOLOGY TO TRANSFORM HEALTHCARE IN THE DIGITAL AGE

    3D-printed, bio-engineered heart in April 2019, to where we are now - a bionic hybrid heart developed in January this year. ... Engineered hearts: Mentioned above, 3D printed bio-engineered hearts created from a patient’s own cells remove the need for

  • Putting people and the planet first in 2020

    At this years’ ISPOR and BIO-Europe conferences we took the decision that our exhibition stand was to be made using as many recycled and reusable components as possible and would

  • Generating data on long-term outcomes with gene and other advanced therapies

    Long-term monitoring of patients to collect outcome data after treatment with these therapies will be standard practice for the foreseeable future; it will therefore be necessary for bio-pharma and ... Bio-pharma are required to adhere to strict

  • OPEN Health mobilised to support outcomes with gene and other advanced therapies OPEN Health mobilised to support outcomes with gene and other advanced therapies

    The imminent explosion of gene and other advanced therapies brings with it a lot of hope and expectation along with unprecedented challenges faced by bio-pharma - big and small. ... In addition OPEN Health always values opinion leaders in a particular

More from PMHub
Approximately 4 fully matching, plus 30 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics